ANT3273

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameANT3273
Drug Alias NameANT3273ANT-3273
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPancreatic elastase inhibitors
TargetsPancreatic elastase
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveBronchiectasisCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAntabio SAS
China Registration ClassN/A

Develop Information

Active CompaniesAntabio SAS
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic ObstructiveBronchiectasisCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A